Charlotte Roach

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Edward B. Garon, Naiyer A. Rizvi, Rina Hui et al. · New England Journal of Medicine · 2015 · 6.1K citations · Full text

Programmed Death-Ligand 1 Expression and Response to the Anti–Programmed Death 1 Antibody Pembrolizumab in Melanoma

Adil Daud, Jedd D. Wolchok, Caroline Robert et al. · Journal of Clinical Oncology · 2016 · 661 citations · Full text

Immunology, Cell Death, Pathology +18

Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non–Small-cell Lung Cancer

Charlotte Roach, Nancy R. Zhang, Ellie Corigliano et al. · Applied immunohistochemistry & molecular morphology · 2016 · 348 citations · Full text

Immunology, Immunoediting, Pathology +17

Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial

Rina Hui, Edward B. Garon, J.W. Goldman et al. · Annals of Oncology · 2017 · 235 citations · Full text

Development of a Companion Diagnostic for Pembrolizumab in Non–Small Cell Lung Cancer Using Immunohistochemistry for Programmed Death Ligand-1

Marisa Dolled‐Filhart, Charlotte Roach, Grant Toland et al. · Archives of Pathology & Laboratory Medicine · 2016 · 115 citations